Role of the stemness factors sox2, Oct3/4, and nanog in gastric carcinoma

Journal of Surgical Research

Volumn 174, Issue 1, 2012, Pages 130-135

  Matsuoka, Junko ^a   Yashiro, Masakazu ^a   Sakurai, Katsunobu ^a   Kubo, Naoshi ^a   Tanaka, Hiroaki ^a   Muguruma, Kazuya ^a   Sawada, Tetsuji ^a   Ohira, Masaichi ^a   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cancer stem cells; gastric carcinoma; Sox2

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER STEM CELL; CANCER SURVIVAL; GASTRECTOMY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; OCTAMER TRANSCRIPTION FACTOR-3; PROGNOSIS; SOXB1 TRANSCRIPTION FACTORS; STOMACH NEOPLASMS;

EID: 84859108713     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.11.903     Document Type: Article

References (29)

1. M. Al-Hajj, M.S. Wicha, and A. Benito-Hernandez Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci USA 100 2003 3983
2. X Zhang, H Yu, and Y Yang SOX2 in gastric carcinoma, but not Hath1, is related to patients' clinicopathologic features and prognosis J Gastrointest Surg 14 2010 1220
3. Z. Chen, W.R. Xu, and H. Qian Oct4, a novel marker for human gastric cancer J Surg Oncol 99 2009 414
4. Y. Saiki, S. Ishimaru, and K. Mimori Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells Ann Surg Oncol 16 2009 2638
5. T. Reya, S.J. Morrison, and M.F. Clarke Stem cells, cancer, and cancer stem cells Nature 414 2001 105
6. R. Pardal, M.F. Clarke, and S.J. Morrison Applying the principles of stem-cell biology to cancer Nat Rev Cancer 3 2003 895
7. N. Haraguchi, H. Inoue, and F. Tanaka Cancer stem cells in human gastrointestinal cancers Hum Cell 19 2006 24
8. K. Takahashi, K. Tanabe, and M. Ohnuki Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861
9. J. Yu, M.A. Vodyanik, and K. Smuga-Otto Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917
10. Y. Chen, L. Shi, and L. Zhang The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer J Biol Chem 283 2008 17969
11. D. Ponti, A. Costa, and N. Zaffaroni Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties Cancer Res 65 2005 5506
12. Y.C. Chen, H.S. Hsu, and Y.W. Chen Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells PLoS One 3 2008 e2637
13. J Wen, JY Park, and KH Park Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis Pancreas 39 2010 622
14. JM Williamson, N Thairu, and N Katsoulas Impact of portal vein embolization on expression of cancer stem cell markers in regenerated liver and colorectal liver metastases Scand J Gastroenterol 12 2010 1472
15. F.L. Greene, and L.H. Sobin A worldwide approach to the TNM staging system: Collaborative efforts of the AJCC and UICC J Surg Oncol 99 2009 269
16. D.J. Rodda, J.L. Chew, and L.H. Lim Transcriptional regulation of Nanog by OCT4 and SOX2 J Biol Chem 280 2005 24731
17. M. Wegner From head to toes: The multiple facets of Sox proteins Nucleic Acids Res 27 1999 1409
18. M. Wilson, P. Koopman, and S.O.X. Matching Partner proteins and co-factors of the SOX family of transcriptional regulators Curr Opin Genet Dev 12 2002 441
19. Y. Kamachi, M. Uchikawa, and H. Kondoh Pairing SOX off: With partners in the regulation of embryonic development Trends Genet 16 2000 182
20. Y. Sanada, K. Yoshida, and M. Ohara Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: Comparison of expression patterns between invasive components and cancerous or non-neoplastic intraductal components Pancreas 32 2006 164
21. K. Okita, T. Ichisaka, and S. Yamanaka Generation of germline-competent induced pluripotent stem cells Nature 448 2007 313
22. I.H. Park, R. Zhao, and J.A. West Reprogramming of human somatic cells to pluripotency with defined factors Nature 451 2008 141
23. M.F. Clarke, J.E. Dick, and P.B. Dirks Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells Cancer Res 66 2006 9339
24. J. Nichols, B. Zevnik, and K. Anastassiadis Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4 Cell 95 1998 379
25. A Liu, L Cheng, and J Du Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors Am J Surg Pathol 34 2010 697
26. C.E. Hoei-Hansen, K. Almstrup, and J.E. Nielsen Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumors Histopathology 47 2005 48
27. S. Masui, Y. Nakatake, and Y. Toyooka Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells Nature Cell Biol 9 2007 625
28. R. Carlin, D. Davis, and M. Weiss Expression of early transcription factors Oct-4, Sox-2, and Nanog by porcine umbilical cord (PUC) matrix cells Reprod Biol Endocrinol 4 2006 8
29. J.L. Chew, Y.H. Loh, and W. Zhang Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells Mol Cell Biol 25 2005 6031